SHARONBIO — Sharon Bio-Medicine Cashflow Statement
0.000.00%
HealthcareMicro Cap
Annual cashflow statement for Sharon Bio-Medicine, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2015 June 30th | 2016 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 9 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | PRESS | PRESS | PRESS |
| Standards: | IAS | IAS | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,446 | -2,179 | 140 | 177 | 190 |
| Depreciation | |||||
| Non-Cash Items | 37.2 | -120 | -12.9 | -4.57 | -16.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 387 | 1,834 | -195 | -48.4 | 137 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -835 | -315 | 41.6 | 230 | 411 |
| Capital Expenditures | -109 | -14.7 | -43.2 | -45.1 | -49.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 8.25 | 9.63 | 4.75 | 12.7 | 22.1 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -101 | -5.05 | -38.5 | -32.4 | -27.7 |
| Financing Cash Flow Items | -12.3 | 103 | 0.216 | 0.274 | 0.228 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 971 | 262 | 0.216 | 0.274 | 0.228 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 35.8 | -57.7 | 3.36 | 197 | 384 |